Related Experiment Video
Updated: Aug 14, 2026

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain
Published on: March 31, 2022
[Constructing recombinant plasmid with prostate-specific membrane antigen promoter and reverse enhancer and comparing
Hao Zeng1, Yong-Chuan Liao, Fang Wang
1Department of Urology, West China Hospital of Sichuan University, Chengdu 610041, China.
Objective:
To assess the specificity of prostate-specific membrane antigen(PSMA) promoter and enhancer in controlling gene expression and to compare the activity of enhancers in different directions for choosing the most suitable prostate-specific PSMA controlling elements.
Methods:
PSMA enhancer gene was amplified with PCR, then the enhancer gene was subcloned into the expressing vector pEGFP-PSMA(Pro) reversely to construct the recombinant plasmid pEGFP-PSMA(E(r)-p), which was transfected into different cell lines such as LNCaP, PC-3,MCF-7,A549. Green fluorescent protein (GFP) expression was observed and compared to other recombinants constructed previously.
Results:
The recombinant plasmid with reverse enhancer was successfully constructed, the PSMA promoter and enhancer showed modulating activity in PSMA-expressed cell line uniquely. PSMA enhancer could increase 30-fold transcriptional activity over the basal level achieved by PSMA promoter alone, and no impact of the direction on the activity of enhancer was noted.
Conclusion:
PSMA promoter/ enhancer is specific to PSMA-expressed cells. The transcriptional activity of reverse enhancer is similar to that of enhancer. PSMA promoter/enhancer has the potential for use in targeted gene therapy of prostate adenocarcinoma.
More Related Videos
Related Concept Videos
RNA Polymerase II Accessory Proteins
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

